Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121716) titled 'Prospective Registry to Evaluate the Long-Term Safety and Effectiveness of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy' on April 2.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Chinese Academy of Medical Sciences Fuwai Hospital

Condition: Obstructive Hypertrophic Cardiomyopathy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-03

Target Sample Size: Case group:400;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=312111

Disclaimer: Curated by HT Syndication....